| 000 | 01211 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250518074359.0 | ||
| 264 | 0 | _c20210618 | |
| 008 | 202106s 0 0 eng d | ||
| 022 | _a1476-5454 | ||
| 024 | 7 |
_a10.1038/s41433-019-0745-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSharma, Ashish | |
| 245 | 0 | 0 |
_aImmunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world data. _h[electronic resource] |
| 260 |
_bEye (London, England) _c06 2020 |
||
| 300 |
_a1008-1009 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aBiosimilar Pharmaceuticals |
| 650 | 0 | 4 | _aDrug Substitution |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aRanibizumab |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHafeez Faridi, M | |
| 700 | 1 | _aKumar, Nilesh | |
| 700 | 1 | _aParachuri, Nikulaa | |
| 700 | 1 | _aSharma, Rohini | |
| 700 | 1 | _aKuppermann, Baruch D | |
| 700 | 1 | _aBandello, Francesco | |
| 700 | 1 | _aLoewenstein, Anat | |
| 700 | 1 | _aRegillo, Carl D | |
| 773 | 0 |
_tEye (London, England) _gvol. 34 _gno. 6 _gp. 1008-1009 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41433-019-0745-z _zAvailable from publisher's website |
| 999 |
_c30427558 _d30427558 |
||